PUBLISHER: The Business Research Company | PRODUCT CODE: 1826799
PUBLISHER: The Business Research Company | PRODUCT CODE: 1826799
Interventional neuroradiology (INR) is a specialized medical field that focuses on the use of minimally invasive techniques to diagnose and treat neurological conditions affecting the brain, spine, and blood vessels. This approach employs advanced imaging methods to guide procedures such as catheter-based treatments, angioplasties, stent placements, and embolization.
The primary devices used in interventional neuroradiology include microcatheters, neurovascular embolization and coiling assist devices, embolic coils, flow diversion devices, liquid embolic agents, accessories, and micro guidewires. Microcatheters are thin, flexible tubes designed to navigate intricate and small blood vessels in the brain and spine during procedures. These devices are utilized in treating conditions such as cerebral aneurysms, intracranial tumors, acute strokes, and others, with applications across various settings such as hospitals, ambulatory surgical centers, and diagnostic centers.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The interventional neuroradiology market research report is one of a series of new reports from The Business Research Company that provides interventional neuroradiology market statistics, including interventional neuroradiology industry global market size, regional shares, competitors with an interventional neuroradiology market share, detailed interventional neuroradiology market segments, market trends and opportunities, and any further data you may need to thrive in the interventional neuroradiology industry. This interventional neuroradiology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The interventional neuroradiology market size has grown strongly in recent years. It will grow from $1.94 billion in 2024 to $2.05 billion in 2025 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to wider acceptance of catheter-based intervention, expanding healthcare infrastructure, rising prevalence of hypertension, rising prevalence of diabetes, and expansion of telemedicine.
The interventional neuroradiology market size is expected to see strong growth in the next few years. It will grow to $2.59 billion in 2029 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to introduction of liquid embolic agent, adoption of endovascular treatment methods, rise in use of mechanical throbectomy, growing reliance on detachable embolic coils, and increasing deployment of bioresobable scaffolds. Major trends in the forecast period include advancements in navigation systems, innovations in radiolucent support devices, integration of artificial intelligence in neuroimaging devices, optimization of thrombectomy devices, and intervention of artificial intelligence in intervention devices.
The forecast of 5.9% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of neurovascular stents and flow diversion devices sourced from France and Ireland, thereby delaying stroke interventions and elevating neurointerventional lab costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The increasing prevalence of neurological disorders is anticipated to drive the growth of the interventional neuroradiology market. These disorders, which affect the brain, spinal cord, or peripheral nerves, can impair movement, sensation, cognition, or communication. The rise in neurological conditions is largely attributed to the aging global population, which heightens the risk of age-related diseases such as Alzheimer's. Additionally, advancements in diagnostic technologies enable earlier and more precise detection of these disorders. Interventional neuroradiology uses minimally invasive, image-guided methods to diagnose and treat conditions such as aneurysms, strokes, and arteriovenous malformations. For example, Alzheimer's Research UK reported in May 2023 that dementia was the leading cause of death in the UK in 2022, with over 74,000 deaths, reflecting a rise of 5,000 from the previous year. As a result, the increasing number of neurological disorders is fueling the growth of the interventional neuroradiology market.
Key players in the interventional neuroradiology market are focusing on developing advanced solutions such as head immobilizers to improve imaging quality and patient safety during neuroradiology and interventional radiology procedures. A head immobilizer is a medical device designed to temporarily immobilize a patient's head and neck, primarily for safety and stability when a head or spinal injury is suspected. For instance, in June 2023, Adept Medical, a New Zealand-based manufacturer, introduced a new head immobilizer that enhances patient comfort and imaging quality during these procedures. The device features vacuum suction technology for secure head fixation, a radiolucent design that minimizes interference with X-ray imaging, and compatibility with various imaging tables. Its quick setup process improves workflow efficiency, and its ability to accommodate different head shapes ensures patient comfort.
In January 2023, GE Healthcare Technologies Inc., a US-based healthcare company, acquired IMACTIS, a France-based medical technology company specializing in computed tomography for navigation systems. The terms of the acquisition were not disclosed. With this acquisition, GE Healthcare intends to improve its interventional guidance offerings by integrating CT-Navigation technology, thereby enhancing procedural accuracy, reducing variability, and expanding its capabilities in interventional radiology. This acquisition also aims to scale IMACTIS's solutions across various medical fields.
Major players in the interventional neuroradiology market are Bayer HealthCare, Abbott Laboratories, Medtronic PLC, Siemens Healthineers AG, Fujifilm Corporation, Philips Healthcare, Stryker Corporation, GE Healthcare Life Sciences, Boston Scientific Corporation, Terumo Corporation, Canon Medical Systems Corporation, W. L. Gore & Associates Inc., Teleflex Incorporated, Cook Medical LLC, Biotronik SE & Co. KG, Merit Medical Systems Inc., MicroPort Scientific Corporation, Penumbra Inc., Guerbet Group, Mediterra LLC, Acandis GmbH, and Medico's Hirata Inc.
North America was the largest region in the interventional neuroradiology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in interventional neuroradiology report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the interventional neuroradiology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The interventional neuroradiology market consists of revenues earned by entities by providing services such as embolization procedures, balloon angioplasty, endovascular coiling, and mechanical thrombectomy. The market value includes the value of related goods sold by the service provider or included within the service offering. The interventional neuroradiology market also includes sales of embolization agents, guidewires, microsurgical instruments, and neurovascular catheters. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Interventional Neuroradiology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on interventional neuroradiology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for interventional neuroradiology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The interventional neuroradiology market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.